155 related articles for article (PubMed ID: 27698881)
1. Impact of intense systemic therapy and improved survival on the use of palliative radiotherapy in patients with bone metastases from prostate cancer.
Nieder C; Haukland E; Mannsåker B; Norum J
Oncol Lett; 2016 Oct; 12(4):2930-2935. PubMed ID: 27698881
[TBL] [Abstract][Full Text] [Related]
2. Survival analysis of malignant epidural spinal cord compression after palliative radiotherapy using Tokuhashi scoring system and the impact of systemic therapy.
Mui WH; Lam TC; Wong FCS; Sze WK
Ann Palliat Med; 2017 Dec; 6(Suppl 2):S132-S139. PubMed ID: 29156895
[TBL] [Abstract][Full Text] [Related]
3. Patterns of practice in palliative radiotherapy for painful bone metastases: impact of a regional rapid access clinic on access to care.
Wu JS; Kerba M; Wong RK; Mckimmon E; Eigl B; Hagen NA
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):533-8. PubMed ID: 19910133
[TBL] [Abstract][Full Text] [Related]
4. Utilization of palliative radiotherapy for breast cancer patients with bone metastases treated with bisphosphonates-Toronto Sunnybrook Regional Cancer Centre experience.
Enright K; Clemons M; Chow E
Support Care Cancer; 2004 Jan; 12(1):48-52. PubMed ID: 14577020
[TBL] [Abstract][Full Text] [Related]
5. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
6. Bone metastases in breast cancer: Frequency, metastatic pattern and non-systemic locoregional therapy.
Steinauer K; Huang DJ; Eppenberger-Castori S; Amann E; Güth U
J Bone Oncol; 2014 May; 3(2):54-60. PubMed ID: 26909298
[TBL] [Abstract][Full Text] [Related]
7. Bone metastases: approaches to management.
Janjan N
Semin Oncol; 2001 Aug; 28(4 Suppl 11):28-34. PubMed ID: 11544573
[TBL] [Abstract][Full Text] [Related]
8. [Palliative Radiotherapy for Bone Metastases].
Nagakura H
Gan To Kagaku Ryoho; 2015 Nov; 42(11):1346-9. PubMed ID: 26602393
[TBL] [Abstract][Full Text] [Related]
9. Impact of a dedicated palliative radiation oncology service on the use of single fraction and hypofractionated radiation therapy among patients with bone metastases.
Skamene S; Agarwal I; Makar M; Krishnan M; Spektor A; Hertan L; Mouw KW; Taylor A; Noveroske Philbrick S; Balboni T
Ann Palliat Med; 2018 Apr; 7(2):186-191. PubMed ID: 29307209
[TBL] [Abstract][Full Text] [Related]
10. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
Brundage MD; Crook JM; Lukka H
Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy for palliation of symptoms in incurable cancer.
Hoegler D
Curr Probl Cancer; 1997; 21(3):129-83. PubMed ID: 9202888
[TBL] [Abstract][Full Text] [Related]
12. Stability and survival analysis of elderly patients with osteolytic spinal bone metastases after palliative radiotherapy : Results from a large multicenter cohort.
Bostel T; Förster R; Schlampp I; Sprave T; Akbaba S; Wollschläger D; Debus J; Mayer A; Schmidberger H; Rief H; Nicolay NH
Strahlenther Onkol; 2019 Dec; 195(12):1074-1085. PubMed ID: 31240346
[TBL] [Abstract][Full Text] [Related]
13. Estimating need for palliative external beam radiotherapy in adult cancer patients.
Nieder C; Pawinski A; Haukland E; Dokmo R; Phillipi I; Dalhaug A
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):207-11. PubMed ID: 19362788
[TBL] [Abstract][Full Text] [Related]
14. Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases.
Hagiwara M; Delea TE; Saville MW; Chung K
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):23-7. PubMed ID: 23146970
[TBL] [Abstract][Full Text] [Related]
15. A systematic overview of radiation therapy effects in skeletal metastases.
Falkmer U; Järhult J; Wersäll P; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):620-33. PubMed ID: 14596519
[TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
17. Survival After Palliative Radiotherapy in Patients with Breast Cancer and Bone-only Metastases.
Nieder C; Dalhaug A; Pawinski A; Mannsåker B; Haukland E
In Vivo; 2016 11-12; 30(6):879-883. PubMed ID: 27815475
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
19. A Population-Based Study of Palliative Radiation Therapy for Bone Metastases in Patients Dying of Prostate Cancer.
Cho CJ; Sunderland K; Pickles T; Bachand F; Chi KN; Tyldesley S
Pract Radiat Oncol; 2019 May; 9(3):e274-e282. PubMed ID: 30641243
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
